Fig. 3From: Aging and the impact of global DNA methylation, telomere shortening, and total oxidative status on sarcopenia and frailty syndromeGlobal DNA methylation in analyzed study groups (healthy subjects at 25–30 age old, healthy subjects at above 50 years old, patients with frailty syndrome, geriatric patients and patients with sarcopenia. The results are shown as the median percentage of methylated DNA (5-mC) of total DNA. *p < 0.05 statistical significanceBack to article page